{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:22:02Z","timestamp":1791505322078,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,3]],"date-time":"2012-03-03T00:00:00Z","timestamp":1330732800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11882-012-0252-9","type":"journal-article","created":{"date-parts":[[2012,3,3]],"date-time":"2012-03-03T01:50:23Z","timestamp":1330739423000},"page":"232-239","source":"Crossref","is-referenced-by-count":24,"title":["Diagnostics and New Developments in the Treatment of Ocular Allergies"],"prefix":"10.1007","volume":"12","author":[{"given":"Osmo","family":"Kari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Matti","family":"Saari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,3,3]]},"reference":[{"key":"252_CR1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1056\/NEJM200101043440106","volume":"344","author":"B Key","year":"2001","unstructured":"Key B. Allergy and allergic diseases. Part I N Engl J Med. 2001;344:30\u20137.","journal-title":"Part I. N Engl J Med."},{"key":"252_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaci.2004.10.042","volume":"115","author":"SJ Ono","year":"2005","unstructured":"Ono SJ, Abelson MB. Allergic conjunctivitis update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol. 2005;115:118\u201322.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"252_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/09286580490888799","volume":"11","author":"A Hussain","year":"2004","unstructured":"Hussain A, Awan H, Khan MD. Prevalence of non-vision-impairing conditions in a village in Chakwal district, Punjab, Pakistan. Ophthal Epidemiol. 2004;11(5):413\u201326.","journal-title":"Ophthal Epidemiol."},{"issue":"5","key":"252_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/14656566.3.5.541","volume":"3","author":"L Bielory","year":"2002","unstructured":"Bielory L. Update on ocular allergy treatment. Expert Opin Pharmacother. 2002;3(5):541\u201353.","journal-title":"Expert Opin Pharmacother."},{"issue":"Suppl 1","key":"252_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2008.03716.x","volume":"153","author":"A Leonardi","year":"2008","unstructured":"Leonardi A, Motterle L, Bortolotti M. Allergy and the eye. Clin Exp Immunol. 2008;153 Suppl 1:17\u201321.","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 2","key":"252_CR6","first-page":"61","volume":"19","author":"MD Ib\u00e1\u00f1ez","year":"2009","unstructured":"\u2022\u2022 Ib\u00e1\u00f1ez MD, Garde JM. Allergy in patients under fourteen years of age in Alergol\u00f3gica 2005. J Investig Allergol Clin Immunol. 2009;19 Suppl 2:61\u20138. This is a good review of allergies in childhood.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"3","key":"252_CR7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/17469899.2.3.331","volume":"2","author":"KM Saari","year":"2007","unstructured":"Saari KM, Kari O, Haahtela T. Nonallergic eosinophilic conjunctivitis. Expert Rev Ophthalmol. 2007;2(3):331\u20133.","journal-title":"Expert Rev Ophthalmol."},{"issue":"2","key":"252_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1755-3768.2009.01599.x","volume":"88","author":"O Kari","year":"2010","unstructured":"\u2022\u2022 Kari O, Haahtela T, Laine P, Turunen JP, Kari M, Sarna S, et al. Cellular characteristics of non-allergic eosinophilic conjunctivitis. Acta Ophthalmol Scand. 2010;88(2):245\u201350. This is the first article to characterize the cells typically found in NAEC.","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"252_CR9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1398-9995.2009.02025.x","volume":"64","author":"S Reitamo","year":"2009","unstructured":"\u2022\u2022 Reitamo S, Remitz A, Haahtela T. Hit early and hit hard in atopic dermatitis and not only in asthma. Allergy. 2009;64(4):503\u20134. This article points out the importance of early therapy to prevent chronicity and tissue damage.","journal-title":"Allergy"},{"key":"252_CR10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clae.2008.07.003","volume":"32","author":"DI Chigbu","year":"2009","unstructured":"Chigbu DI. The pathophysiology of ocular allergy: a review. Cont Lens Anterior Eye. 2009;32:3\u201315.","journal-title":"Cont Lens Anterior Eye."},{"issue":"1","key":"252_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.iac.2007.12.006","volume":"28","author":"AM Irani","year":"2008","unstructured":"Irani AM. Ocular mast cells and mediators. Immunol Allergy Clin North Am. 2008;28(1):25\u201342.","journal-title":"Immunol Allergy Clin North Am."},{"issue":"3","key":"252_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1254\/jphs.09R05FM","volume":"110","author":"A Ikoma","year":"2009","unstructured":"Ikoma A. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitis. J Pharmacol Sci. 2009;110(3):265\u20139.","journal-title":"J Pharmacol Sci."},{"key":"252_CR13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/ACI.0b013e32834a41c2","volume":"11","author":"U Raap","year":"2011","unstructured":"\u2022 Raap U, St\u00e4nder S, Metz M. Pathophysiology of itch and new treatments. Curr Opin Clin Allergy Clin Immunol. 2011;11:420\u20137. This article describes the mechanisms of itch and new therapeutic modalities.","journal-title":"Curr Opin Clin Allergy Clin Immunol."},{"issue":"1","key":"252_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1189\/jlb.0108058","volume":"85","author":"LA Spencer","year":"2009","unstructured":"\u2022\u2022 Spencer LA, Szela CT, Perez SA, et al. Human eosinophils constitutively express multiple TH1, Th2 and immunoregulatory cytokines that are secreted rapidly and differentially. J Leukoc Biol. 2009;85(1):117\u201323. This paper shows present insight into the nature of preformed eosinophil cytokines and the functions of human eosinophils in mediating inflammation and initiation of specific immunity.","journal-title":"J Leukoc Biol."},{"key":"252_CR15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2010.02536.x","volume":"66","author":"F Mantelli","year":"2011","unstructured":"\u2022 Mantelli F, Lambiase A, Bonini S, Bonini S. Clinical trials in allergic conjunctivitis: a systematic review. Allergy. 2011;66:919\u201324. This systematic review points out the lack of good controlled treatment studies.","journal-title":"Allergy."},{"issue":"2","key":"252_CR16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF02150945","volume":"223","author":"O Kari","year":"1985","unstructured":"Kari O, Salo OP, Halmepuro L, et al. Tear histamine during allergic conjunctivitis challenge. Graefe\u2019s Arch Clin Exp Ophthalmol. 1985;223(2):60\u20132.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"key":"252_CR17","first-page":"47","volume":"17","author":"M Sacchetti","year":"2011","unstructured":"Sacchetti M, Micera A, Lambiase A, Speranza S, Mantelli F, Petrachi G, et al. Tear levels of neuropeptides after specific allergen challenge in allergic conjunctivitis. Molecular Vision. 2011;17:47\u201352.","journal-title":"Molecular Vision."},{"key":"252_CR18","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ACI.0b013e3283466fcb","volume":"11","author":"J K\u00f6berlein","year":"2011","unstructured":"K\u00f6berlein J, Kothe AC, Schaffert C. Determinants of patients compliance in allergic rhinoconjunctivitis. Curr Opin Allergy Clin Immunol. 2011;11:192\u20139.","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"252_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11882-011-0188-5","volume":"11","author":"MB Abelson","year":"2011","unstructured":"\u2022 Abelson MB, McLaughlin JT, Gomes PJ. Antihistamines in ocular allergy: are they all created equal? Curr Allergy Asthma Rep. 2011;11:205\u201311. This article tells the well-known truth that there are no major differences among currently available antihistamines.","journal-title":"Curr Allergy Asthma Rep."},{"key":"252_CR20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1185\/03007995.2010.548797","volume":"27","author":"G Torkildsen","year":"2011","unstructured":"Torkildsen G, Shedden A. The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis. Curr Med Res Opin. 2011;27:623\u201331.","journal-title":"Curr Med Res Opin."},{"key":"252_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/108076804773710812","volume":"20","author":"P Gous","year":"2004","unstructured":"Gous P, Ropo A. A comparison trial of the safety and efficacy of 0.1% percent pemiroplast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis. Ocul Pharmacol Ther. 2004;20:139\u201350.","journal-title":"Ocul Pharmacol Ther"},{"issue":"3","key":"252_CR22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jaci.2009.12.931","volume":"125","author":"D Skoner","year":"2010","unstructured":"Skoner D, Gentile D, Bush R, et al. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen. J Allergy Clin Immunol. 2010;125(3):660\u20136.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"252_CR23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2222.2008.03152.x","volume":"39","author":"H-J Malling","year":"2009","unstructured":"Malling H-J, Montagut A, Melac M, et al. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis. Clin Exp Allergy. 2009;39(3):387\u201393.","journal-title":"Clin Exp Allergy"},{"issue":"Suppl 91","key":"252_CR24","first-page":"1","volume":"64","author":"GW Canonica","year":"2009","unstructured":"\u2022\u2022 Canonica GW, Bousquet J, Casale T, et al. Sublingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy. 2009;64 Suppl 91:1\u201359. This article presents basic knowledge about sublingual immunotherapy.","journal-title":"Allergy."},{"key":"252_CR25","first-page":"CD007685","volume":"6","author":"MA Calderon","year":"2011","unstructured":"Calderon MA, Penagos M, Sheikh A, Canonica GW, Durham S. Sublingual immunotherapy for treating allergic conjunctivitis. Cochrane Database Syst Rev. 2011;6:CD007685.","journal-title":"Cochrane Database Syst Rev"},{"key":"252_CR26","volume-title":"Ocular therapeutics: eye on new discoveries","author":"JM Yanni","year":"2008","unstructured":"Yanni JM, Barney NP. Ocular allergy: clinical, therapeutic and drug discovery consideration. In: Yorio T, Clark A, Wax M, editors. Ocular therapeutics: eye on new discoveries. USA: Elsevier; 2008."},{"key":"252_CR27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e3283303e2e","volume":"9","author":"I Offiah","year":"2009","unstructured":"\u2022 Offiah I, Calder VL. Immune mechanisms in allergic eye diseases: what is new? Curr Opin Allergy Clin Immunol. 2009;9:477\u201381. This is a newer review about mechanisms in allergic eye diseases.","journal-title":"Curr Opin Allergy Clin Immunol."},{"issue":"3","key":"252_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1067\/mai.2001.113521","volume":"107","author":"S Reitamo","year":"2001","unstructured":"Reitamo S. Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol. 2001;107(3):445\u20138.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"252_CR29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1600-0420.2006.00699.x","volume":"84","author":"HM Virtanen","year":"2006","unstructured":"Virtanen HM, Reitamo S, Kari M, Kari O. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis; a retrospective study. Acta Ophtalmol. 2006;84(5):693\u20135.","journal-title":"Acta Ophtalmol"},{"issue":"3)","key":"252_CR30","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1111\/j.1755-3768.2009.01834.x","volume":"89","author":"A Remitz","year":"2011","unstructured":"\u2022\u2022 Remitz A, Virtanen HM, Reitamo S, Kari O. Tacrolimus ointment in atopic blepharoconjunctivitis does not seem to elevate intraocular pressure. Acta Ophthalmol. 2011;89(3)):e295\u20136. doi: 10.1111\/j.1755-3768.2009.01834.x . This is the first article to show how effective and safe tacrolimus ointment is in treating severe allergic eye disease.","journal-title":"Acta Ophthalmol"},{"key":"252_CR31","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","volume":"25","author":"N Ebihara","year":"2009","unstructured":"\u2022 Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2009;25:365\u201372. This article confirms the safety of topical cyclosporine drops in treatment of severe allergic eye diseases.","journal-title":"J Ocul Pharmacol Ther."},{"key":"252_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1398-9995.1992.tb02056.x","volume":"47","author":"O Kari","year":"1992","unstructured":"Kari O, Haahtela T. Is atopy a risk factor for the use of contact lenses? Allergy. 1992;47:295\u20138.","journal-title":"Allergy."},{"issue":"3","key":"252_CR33","first-page":"151","volume":"27","author":"O Kari","year":"2001","unstructured":"Kari O, Teir H, Huuskonen R, et al. Tolerance to different kinds of contact lenses in young atopic and non-atopic wearers. CLAO. 2001;27(3):151\u20134.","journal-title":"CLAO."},{"issue":"3","key":"252_CR34","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1755-3768.1992.tb08574.x","volume":"70","author":"O Kari","year":"1992","unstructured":"Kari O, Haahtela T. Conjunctival eosinophilia in atopic and non-atopic external eye symptoms. Acta Ophthalmol. 1992;70(3):335\u201340.","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"252_CR35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jaci.2003.08.009","volume":"112","author":"JU Ponikaus","year":"2003","unstructured":"Ponikaus JU, Sherris DA, Kephart GM, et al. Features of airway remodelling and eosinophilic inflammation in chronic rhinosinusitis. J Allergy Clin Immunol. 2003;112(5):877\u201382.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"252_CR36","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1164\/ajrccm.150.4.7921434","volume":"150","author":"C Walker","year":"1994","unstructured":"Walker C, Bauer W, Braun RK, et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med. 1994;150(4):1038\u201348.","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"252_CR37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1755-3768.1988.tb04027.x","volume":"66","author":"O Kari","year":"1988","unstructured":"Kari O. Atopic conjunctivitis. A cytologic examination. Acta Ophthalmol. 1988;66(4):381\u20136.","journal-title":"Acta Ophthalmol."},{"issue":"3","key":"252_CR38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1610-0387.2009.07216_supp.x","volume":"8","author":"A Feser","year":"2010","unstructured":"Feser A, Mahler V. Periorbital dermatitis: causes, differential diagnoses and therapy. J Dtsch Dermatol Ges. 2010;8(3):159\u201366.","journal-title":"J Dtsch Dermatol Ges."},{"issue":"7","key":"252_CR39","first-page":"1017","volume":"75","author":"WF Peate","year":"2007","unstructured":"Peate WF. Work related eye injuries and illnesses. Am Family Phys. 2007;75(7):1017\u201322.","journal-title":"Am Family Phys."},{"issue":"5","key":"252_CR40","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/09273940802283323","volume":"16","author":"S Peltonen","year":"2008","unstructured":"Peltonen S, Kari O, Jarva H, et al. Complement activation in tear fluid during occupational mold challenge. Ocul Immunol Inflamm. 2008;16(5):224\u20139.","journal-title":"Ocul Immunol Inflamm."},{"key":"252_CR41","first-page":"203","volume-title":"Allergologia","author":"O Kari","year":"1999","unstructured":"Kari O, Hannuksela M. Silm\u00e4n yliherkkyyssairaudet. In: Haahtela T, Hannuksela M, Terho EO, editors. Allergologia. Helsinki: Kustannus Oy Duodecim; 1999. p. 203\u201313."},{"issue":"1","key":"252_CR42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1755-3768.1985.tb05224.x","volume":"63","author":"O Kari","year":"1985","unstructured":"Kari O, Salo OP, Bj\u00f6rkst\u00e9n F, Backman A. Allergic conjunctivitis, total and specific IgE in the tear fluid. Acta Ophthalmol. 1985;63(1):97\u20139.","journal-title":"Acta Ophthalmol"},{"key":"252_CR43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/JOM.0b013e318181ff05cc","volume":"53","author":"H L\u00f6fstedt","year":"2011","unstructured":"L\u00f6fstedt H, Westberg H, Seld\u00e9n AI, Rublad S, Bryngelsson IL, Ngo Y, et al. Nasal and ocular effects in foundry workers using the hot box method. J Occup Environ Med. 2011;53:43\u20138.","journal-title":"J Occup Environ Med."}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0252-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-012-0252-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-012-0252-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:42:27Z","timestamp":1559432547000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-012-0252-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["252"],"URL":"https:\/\/doi.org\/10.1007\/s11882-012-0252-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,3]]}}}